Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:CASNumber |
1629639-44-8
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Aileron_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALRN-6924
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:macromoleculeType |
stapled peptide
|
| gptkbp:mechanismOfAction |
MDM2 inhibitor
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
p53 pathway
|
| gptkbp:bfsParent |
gptkb:Aileron_Therapeutics
|
| gptkbp:bfsLayer |
5
|